Stock Code: 002412 Stock Abbreviation: Hansen Pharmaceutical Announcement No.: 2026-003 Hunan Hansen Pharmaceutical Co., Ltd. Announcement on the 2025 Profit Distribution Plan
The Company and all members of the Board of Directors guarantee the content of the information disclosure is true, accurate, and complete, and that there are no false records, misleading statements, or major omissions.
Hunan Hansen Pharmaceutical Co., Ltd. (hereinafter referred to as the "Company") held the eleventh meeting of the Sixth Board of Directors on April 24, 2026, and deliberated and passed the "2025 Profit Distribution Plan". This proposal will be submitted to the Company's shareholders' meeting for deliberation. The relevant matters are hereby announced as follows:
I. Deliberation Procedures
(I) Audit Committee Review
The second meeting of the Company's Board of Directors' Audit Committee in 2026 deliberated and passed the "2025 Profit Distribution Plan". The attending members believed that the profit distribution plan is in line with the Company's actual situation and the provisions of the "Company Articles of Association", and found no circumstances that harm the interests of shareholders, especially small and medium shareholders. They agreed to the profit distribution plan for the current year.
(II) Board of Directors Review
The Board of Directors believes that the Company's profit distribution plan takes into account the Company's current and future investment capital needs, operating fund turnover, and other actual circumstances. It complies with the provisions of the "Company Law" and the "Company Articles of Association", does not harm the interests of the Company's shareholders, especially small and medium shareholders, and is conducive to the Company's normal operation and healthy development. The Board of Directors agreed to submit the "2025 Profit Distribution Plan" to the Company's shareholders' meeting for deliberation.